カテゴリ： MarketLine, ドイツ, 企業調査

Merz Pharma GmbH & Co. KGaA：企業のM&A・事業提携・投資動向

◆英語タイトル：Merz Pharma GmbH & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード：DATA904C2097
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：276
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD700 ⇒換算￥103,600見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD1,050 ⇒換算￥155,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Merz Pharma GmbH & Co. KGaA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Merz Pharma GmbH & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Merz Pharma GmbH & Co. KGaA since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Merz Pharma GmbH & Co. KGaA’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Merz Pharma GmbH & Co. KGaA. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Merz Pharma GmbH & Co. KGaA’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Merz Pharma GmbH & Co. KGaA and its subsidiaries since 2007.
- Information about key financial and legal advisors for Merz Pharma GmbH & Co. KGaA’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Merz Pharma GmbH & Co. KGaA’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 28
Corporate Venturing – Overview 28
Corporate Venturing – Deal reports 29
PARTNERSHIP 31
Partnership – Deal reports 31
DIVESTMENTS 261
Divestments – Overview 261
Divestments – Deal reports 262
APPENDIX 266
Contact Us 266
About MarketLine Financial Deals Database 266
Deal Definition and Methodology 268
About MarketLine 275

List of Tables
Table 1: Merz Pharma GmbH & Co. KGaA M&A volume and value trend (2014-YTD2018)
Table 2: Merz Pharma GmbH & Co. KGaA M&A activity by geography (2014-YTD2018)
Table 3: Merz Pharma GmbH & Co. KGaA corporate venturing volume and value trend (2014-YTD2018)
Table 4: Merz Pharma GmbH & Co. KGaA corporate venturing by geography (2014-YTD2018)
Table 5: Merz Pharma GmbH & Co. KGaA divestments volume and value trend (2014-YTD2018)
Table 6: Merz Pharma GmbH & Co. KGaA divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Merz Pharma GmbH & Co. KGaA M&A volume and value trend (2014-YTD2018)
Figure 2: Merz Pharma GmbH & Co. KGaA M&A activity by geography (2014-YTD2018)
Figure 3: Merz Pharma GmbH & Co. KGaA corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Merz Pharma GmbH & Co. KGaA corporate venturing by geography (2014-YTD2018)
Figure 5: Merz Pharma GmbH & Co. KGaA divestments volume and value trend (2014-YTD2018)
Figure 6: Merz Pharma GmbH & Co. KGaA divestments by geography (2014-YTD2018)

★海外企業調査レポート[Merz Pharma GmbH & Co. KGaA：企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • The Boeing Company：企業の戦略・SWOT・財務情報
    The Boeing Company - Strategy, SWOT and Corporate Finance Report Summary The Boeing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Marubeni Corp (8002)：企業の財務・戦略的SWOT分析
    Marubeni Corp (8002) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Amphenol Corporation：企業の戦略・SWOT・財務情報
    Amphenol Corporation - Strategy, SWOT and Corporate Finance Report Summary Amphenol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bashas’ Inc.：企業の戦略・SWOT・財務情報
    Bashas' Inc. - Strategy, SWOT and Corporate Finance Report Summary Bashas' Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Intra-Cellular Therapies Inc (ITCI)：製薬・医療：M&Aディール及び事業提携情報
    Summary Intra-Cellular Therapies Inc (ITI) is a novel drug manufacturer. The company offers product platform such as ITCI Pipeline that includes lumateperone, ITI-007 platform, PDE inhibitor platform and drug discovery platform. The company’s lead product candidate ITI-007-lumateperone is to treat s …
  • Exandal Corp.：企業の戦略・SWOT・財務情報
    Exandal Corp. - Strategy, SWOT and Corporate Finance Report Summary Exandal Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nice-Pak Products, Inc.：企業の戦略・SWOT・財務情報
    Nice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Novo Nordisk AS (NOVO B)：医療機器：M&Aディール及び事業提携情報
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Labco SA-製薬・医療分野：企業M&A・提携分析
    Summary Labco SA (Labco) is a medical diagnostic company that provides clinical laboratory services. The company provides detection and prevention of chronic and severe disorders. Its medical services include laboratory, internal analysis and transmission of internal results and diagnostic interpret …
  • Praxair Inc (PX)：石油・ガス：M&Aディール及び事業提携情報
    Summary Praxair Inc (Praxair) is a producer and supplier of industrial gases. The company produces atmospheric gases including oxygen, nitrogen, argon and rare gases, and process gases such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases and acetylene. It also designs and buil …
  • Cardiva Medical Inc：企業の戦略的SWOT分析
    Cardiva Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Smartac Group China Holdings Ltd (395)：企業の財務・戦略的SWOT分析
    Smartac Group China Holdings Ltd (395) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Fuji Pharma Co Ltd (4554)：企業の財務・戦略的SWOT分析
    Summary Fuji Pharma Co Ltd (Fuji Pharma) develops, manufactures, and commercializes pharmaceutical products. The company specializes in offering injection agents, drugs for external use, internal drugs, and diagnostic products among others. It also provides medical care products for women, acute med …
  • Sulzer Ltd (SUN)：石油・ガス：M&Aディール及び事業提携情報
    Summary Sulzer Ltd (Sulzer) is an industrial engineering company that manufactures and supplies pump equipment. It offers mixers, compressors, agitators and aeration equipment. The company provides repair and maintenance service solutions for turbines, pumps, compressors, motors, and generators. Sul …
  • Yum! Brands, Inc.：企業の戦略・SWOT・財務情報
    Yum! Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Yum! Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Arcbest Corp.
    Arcbest Corp. - Strategy, SWOT and Corporate Finance Report Summary Arcbest Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SMA Solar Technology AG (S92)-エネルギー分野：企業M&A・提携分析
    Summary SMA Solar Technology AG (SMA) is a renewable energy company that develops, produces, and distributes photovoltaic (PV) inverters, transformers, choke coils, and monitoring and energy management systems for PV systems. It also offers operation and maintenance services for photovoltaic power p …
  • Veritone, Inc. (VERI)：企業の財務・戦略的SWOT分析
    Veritone, Inc. (VERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Axpo Holding AG：電力：M&Aディール及び事業提携情報
    Summary Axpo Holding AG (Axpo) is an energy utility. It produces, trades and sells energy. The company generates electricity from hydro, nuclear, and gas sources. Axpo owns and operates power-generating plants and distribution grids in various countries. It carries out energy trading, risk and portf …
  • Agilent Technologies, Inc.：戦略・SWOT・企業財務分析
    Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆